369 related articles for article (PubMed ID: 15728808)
1. Effectiveness of mass oral cholera vaccination in Beira, Mozambique.
Lucas ME; Deen JL; von Seidlein L; Wang XY; Ampuero J; Puri M; Ali M; Ansaruzzaman M; Amos J; Macuamule A; Cavailler P; Guerin PJ; Mahoudeau C; Kahozi-Sangwa P; Chaignat CL; Barreto A; Songane FF; Clemens JD
N Engl J Med; 2005 Feb; 352(8):757-67. PubMed ID: 15728808
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia.
Concha A; Giraldo A; Castañeda E; Martínez M; de la Hoz F; Rivas F; Depetris A; Svennerholm AM; Sack DA
Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera.
Murray J; McFarland DA; Waldman RJ
Bull World Health Organ; 1998; 76(4):343-52. PubMed ID: 9803585
[TBL] [Abstract][Full Text] [Related]
4. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam.
Trach DD; Cam PD; Ke NT; Rao MR; Dinh D; Hang PV; Hung NV; Canh DG; Thiem VD; Naficy A; Ivanoff B; Svennerholm AM; Holmgren J; Clemens JD
Bull World Health Organ; 2002; 80(1):2-8. PubMed ID: 11884967
[TBL] [Abstract][Full Text] [Related]
5. Two-year study of the protective efficacy of the oral whole cell plus recombinant B subunit cholera vaccine in Peru.
Taylor DN; Cárdenas V; Sanchez JL; Bégué RE; Gilman R; Bautista C; Perez J; Puga R; Gaillour A; Meza R; Echeverria P; Sadoff J
J Infect Dis; 2000 May; 181(5):1667-73. PubMed ID: 10823767
[TBL] [Abstract][Full Text] [Related]
6. Reduction of travellers' diarrhoea by WC/rBS oral cholera vaccine in young, high-risk travellers.
Torrell JM; Aumatell CM; Ramos SM; Mestre LG; Salas CM
Vaccine; 2009 Jun; 27(30):4074-7. PubMed ID: 19376179
[TBL] [Abstract][Full Text] [Related]
7. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam.
Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR
Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909
[TBL] [Abstract][Full Text] [Related]
8. Is HIV infection associated with an increased risk for cholera? Findings from a case-control study in Mozambique.
von Seidlein L; Wang XY; Macuamule A; Mondlane C; Puri M; Hendriksen I; Deen JL; Chaignat CL; Clemens JD; Ansaruzzaman M; Barreto A; Songane FF; Lucas M
Trop Med Int Health; 2008 May; 13(5):683-8. PubMed ID: 18331384
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique.
Cavailler P; Lucas M; Perroud V; McChesney M; Ampuero S; Guérin PJ; Legros D; Nierle T; Mahoudeau C; Lab B; Kahozi P; Deen JL; von Seidlein L; Wang XY; Puri M; Ali M; Clemens JD; Songane F; Baptista A; Ismael F; Barreto A; Chaignat CL
Vaccine; 2006 May; 24(22):4890-5. PubMed ID: 16298025
[TBL] [Abstract][Full Text] [Related]
10. A review of the current status of enteric vaccines.
Levine MM; Noriega F
P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
[TBL] [Abstract][Full Text] [Related]
11. [Community trial for safety and immunogenicity of oral-administered lyophilized rBS-WC cholera vaccine].
Chen Q; Yu S; Wang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 1996 Nov; 30(6):330-3. PubMed ID: 9388905
[TBL] [Abstract][Full Text] [Related]
12. Cholera vaccine field trials in east Pakistan. 2. Effectiveness in the field.
Benenson AS; Mosley WH; Fahimuddin M; Oseasohn RO
Bull World Health Organ; 1968; 38(3):359-72. PubMed ID: 5302329
[TBL] [Abstract][Full Text] [Related]
13. Oral vaccines for cholera control.
Chaturvedi S; Chaturvedi S
Natl Med J India; 1997; 10(1):17-8. PubMed ID: 9069701
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness in prevention of travellers' diarrhoea by an oral cholera vaccine WC/rBS.
López-Gigosos R; García-Fortea P; Reina-Doña E; Plaza-Martín E
Travel Med Infect Dis; 2007 Nov; 5(6):380-4. PubMed ID: 17983977
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis.
Jeuland M; Cook J; Poulos C; Clemens J; Whittington D;
Value Health; 2009 Sep; 12(6):899-908. PubMed ID: 19824189
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study.
Khatib AM; Ali M; von Seidlein L; Kim DR; Hashim R; Reyburn R; Ley B; Thriemer K; Enwere G; Hutubessy R; Aguado MT; Kieny MP; Lopez AL; Wierzba TF; Ali SM; Saleh AA; Mukhopadhyay AK; Clemens J; Jiddawi MS; Deen J
Lancet Infect Dis; 2012 Nov; 12(11):837-44. PubMed ID: 22954655
[TBL] [Abstract][Full Text] [Related]
17. Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission.
Ali M; Emch M; Yunus M; Sack D; Lopez AL; Holmgren J; Clemens J
Pediatr Infect Dis J; 2008 Jan; 27(1):33-7. PubMed ID: 18162935
[TBL] [Abstract][Full Text] [Related]
18. Coverage and costs of mass immunization of an oral cholera vaccine in Vietnam.
Vu DT; Hossain MM; Nguyen DS; Nguyen TH; Rao MR; Do GC; Naficy A; Nguyen TK; Acosta CJ; Deen JL; Clemens JD; Dang DT
J Health Popul Nutr; 2003 Dec; 21(4):304-8. PubMed ID: 15043004
[TBL] [Abstract][Full Text] [Related]
19. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp.
Legros D; Paquet C; Perea W; Marty I; Mugisha NK; Royer H; Neira M; Ivanoff B
Bull World Health Organ; 1999; 77(10):837-42. PubMed ID: 10593032
[TBL] [Abstract][Full Text] [Related]
20. Current status of cholera and rise of novel mucosal vaccine.
Yamamoto T
Jpn J Infect Dis; 2000 Oct; 53(5):181-8. PubMed ID: 11135702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
